Taking vitamin E does not impact women's heart failure risk

March 20, 2012 in Cardiology

Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal.

The study is the first to investigate the effectiveness of to prevent the development of heart failure. Researchers studied nearly 40,000 women in the Women's who took 600 International Units of vitamin E or placebo every other day. The women were age 45 or older and healthy at the study's start. Researchers followed them for an average 10.2 years to determine if taking the supplement affected heart failure risk. Investigators recorded 220 heart failure cases.

Overall, researchers found no impact from vitamin E supplementation.

They did, however, observe a 41 percent decrease in the risk of developing a type of heart failure in which the heart retains its normal pumping function. This sub finding is only an observation and topic for future research, said Claudia U. Chae, M.D., M.P.H, lead researcher in the cardiology division at Massachusetts General Hospital in Boston.

They conclude: vitamin E does not prevent heart failure. Prevention strategies should instead focus on what has been shown in research to reduce risk, such as controlling blood pressure and preventing heart disease.

Provided by American Heart Association search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Cardiology created 5 hours ago | popularity not rated yet | comments 1

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Cardiology created 5 hours ago | popularity 5 / 5 (1) | comments 4

Registry confirms TAVI efficacy and safety in Asian patients

Transcatheter aortic valve implantation (TAVI) is effective and safe in Asian patients, according to early experience based on first results from a multicentre Asian registry reported at EuroPCR 2013.

Cardiology created May 24, 2013 | popularity not rated yet | comments 0

Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases

Routinely measuring fractional flow reserve (FFR) using pressure wire assessment during coronary angiography for diagnosis of chest pain leads to significant changes in the management of one in four patients, according to ...

Cardiology created May 24, 2013 | popularity not rated yet | comments 0


Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Pollen count apps for smartphones are nothing to sneeze at

Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.